WENDY GILRAINE: Open Payments
NPI 1275060840 · MARTINSVILLE, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,009 in 113 payments from 15 companies in 2025. Trend: 2023 $1,988 · 2024 $1,623 · 2025 $2,009
Food & beverage: $1,947Education: $63
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 23 | $576 |
| GlaxoSmithKline, LLC. | 17 | $261 |
| Mallinckrodt Hospital Products Inc. | 12 | $242 |
| Insmed, Inc. | 13 | $189 |
| Regeneron Healthcare Solutions, Inc. | 19 | $177 |
| Genentech USA, Inc. | 5 | $175 |
| Philips North America LLC | 5 | $102 |
| Electromed, Inc. | 9 | $95 |
| United Therapeutics Corporation | 3 | $53 |
| Verona Pharma, Inc. | 2 | $36 |
Products named: TEZSPIRE, ACTHAR, NUCALA, DUPIXENT, Xolair, Arikayce, FASENRA, Vest Therapy Und.
Industry payments across VA — which companies pay providers there.
